Related Experiment Video
Updated: Mar 7, 2026
07:38
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
878
GHetting to know ADPKD proliferative signaling, STAT
Ching-Hsien Chen1, Robert H Weiss2
1Division of Nephrology, Department of Internal Medicine, University of California, Davis, California.
Kidney International
|February 17, 2017
Summary
Polycystic kidney disease shares pathways with cancer. This study identifies signal transducer and activator of transcription (STAT5) and growth hormone (GH) as key targets for potential therapeutic interventions.
Area of Science:
- Oncology
- Nephrology
- Endocrinology
Background:
- Cystic diseases and cancer share common pathogenesis and proliferative signaling pathways.
- Recent research links cystic diseases to cancer biology, suggesting shared molecular mechanisms.
- Polycystic kidney disease (PKD) involves complex signaling pathways that may be amenable to therapeutic targeting.
Purpose of the Study:
- To investigate the role of signal transducer and activator of transcription 5 (STAT5) and growth hormone (GH) in polycystic kidney disease.
- To identify potentially modifiable pathways in PKD based on cancer biology paradigms.
- To explore GH as a potential biomarker and therapeutic target in PKD.
Main Methods:
- The study builds upon existing research connecting cystic diseases and cancer biology.
- It focuses on identifying specific molecular pathways, namely STAT5 and GH, within the context of PKD.
- The research explores the potential of these pathways for therapeutic intervention and biomarker development.
Main Results:
- Signal transducer and activator of transcription 5 (STAT5) was identified as a key pathway in polycystic kidney disease.
- Growth hormone (GH) was implicated as a potent activator of STAT5 and a potential biomarker in PKD.
- The findings suggest GH may offer a mechanism of action for somatostatin analogs used in clinical trials.
Conclusions:
- STAT5 and GH represent potentially modifiable pathways in polycystic kidney disease.
- Growth hormone (GH) shows promise as a biomarker for PKD and may explain the efficacy of somatostatin analogs.
- This research opens new avenues for therapeutic strategies in PKD by targeting identified signaling pathways.
More Related Videos
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
9.3K
08:46Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
10.3K
Related Concept Videos
01:22PI3K/mTOR/AKT Signaling Pathway
6.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.0K
01:19Interactions Between Signaling Pathways
7.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.6K
01:20The JAK-STAT Signaling Pathway
13.5K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.5K
01:22Amplifying Signals via Enzymatic Cascade
18.9K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
18.9K
01:25cAMP-dependent Protein Kinase Pathways
8.8K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.8K
01:07MAPK Signaling Cascades
8.9K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.9K